Cargando…

Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder

Several studies have demonstrated that allelic variants related to inflammation and the immune system may increase the risk for major depressive disorder (MDD) and reduce patient responsiveness to antidepressant treatment. Proteasomes are fundamental complexes that contribute to the regulation of T-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minelli, A, Magri, C, Barbon, A, Bonvicini, C, Segala, M, Congiu, C, Bignotti, S, Milanesi, E, Trabucchi, L, Cattane, N, Bortolomasi, M, Gennarelli, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068581/ https://www.ncbi.nlm.nih.gov/pubmed/26624926 http://dx.doi.org/10.1038/tp.2015.180

Ejemplares similares

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder
por: Milanesi, Elena, et al.
Publicado: (2012)

Altered Gene Expression in Schizophrenia: Findings from Transcriptional Signatures in Fibroblasts and Blood
por: Cattane, Nadia, et al.
Publicado: (2015)

The effect of childhood trauma and trauma-focused psychotherapy on blood expression in patients with major depressive disorder
por: Minelli, A., et al.
Publicado: (2021)

The effect of childhood trauma and trauma-focused psychotherapy on blood expression of MED22 in patients with major depressive disorder
por: Minelli, A., et al.
Publicado: (2022)

Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
por: Pisanu, Claudia, et al.
Publicado: (2021)

Methylation changes in association with early life stress and trauma-focused psychotherapy in treatment-resistant depression
por: Carvalho Silva, R., et al.
Publicado: (2023)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
por: Maffioletti, Elisabetta, et al.
Publicado: (2020)

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients
por: Roulot, Morgane, et al.
Publicado: (2018)

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
por: Minelli, Alessandra, et al.
Publicado: (2021)

Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future
por: Maffioletti, Elisabetta, et al.
Publicado: (2021)

Dopamine System Dysregulation in Major Depressive Disorders
por: Belujon, Pauline, et al.
Publicado: (2017)

Dysregulation of the Lateral Habenula in Major Depressive Disorder
por: Browne, Caroline A., et al.
Publicado: (2018)

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
por: Barlati, Stefano, et al.
Publicado: (2023)

Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients
por: Maffioletti, Elisabetta, et al.
Publicado: (2021)

New Copy Number Variations in Schizophrenia
por: Magri, Chiara, et al.
Publicado: (2010)

The role of anxious distress in immune dysregulation in patients with major depressive disorder
por: Gaspersz, Roxanne, et al.
Publicado: (2017)

Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways
por: Giacopuzzi, Edoardo, et al.
Publicado: (2017)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
por: Minelli, A.
Publicado: (2022)

The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits
por: Minelli, Alessandra, et al.
Publicado: (2011)

Dysregulation of the (immuno)proteasome pathway in malformations of cortical development
por: van Scheppingen, J., et al.
Publicado: (2016)

Evidence for Transcriptional Factor Dysregulation in the Dorsal Raphe Nucleus of Patients with Major Depressive Disorder
por: Kerman, Ilan A., et al.
Publicado: (2012)

What is the genetic architecture of major psychiatric disorders?
por: Hennah, W., et al.
Publicado: (2021)

Genome wide analysis implicates upregulation of proteasome pathway in major depressive disorder
por: Belaish, Shaked, et al.
Publicado: (2021)

RNA Editing and Modifications in Mood Disorders
por: Barbon, Alessandro, et al.
Publicado: (2020)

Assessment of haptoglobin alleles in autism spectrum disorders
por: Cupaioli, Francesca Anna, et al.
Publicado: (2020)

Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
por: Giacopuzzi, Edoardo, et al.
Publicado: (2018)

Author Correction: Assessment of haptoglobin alleles in autism spectrum disorders
por: Cupaioli, Francesca Anna, et al.
Publicado: (2023)

Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles
por: Magri, Chiara, et al.
Publicado: (2021)

Resilience Dysregulation in Major Depressive Disorder: Focus on  Glutamatergic Imbalance and Microglial Activation
por: Réus, Gislaine Z., et al.
Publicado: (2018)

The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
por: Dattilo, Vincenzo, et al.
Publicado: (2020)

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases
por: Zheng, Qiuyang, et al.
Publicado: (2016)

Abnormal global signal topography of self modulates emotion dysregulation in major depressive disorder
por: Keskin, Kaan, et al.
Publicado: (2023)

Dysregulation of Prefrontal Oligodendrocyte Lineage Cells Across Mouse Models of Adversity and Human Major Depressive Disorder Oligodendrocyte dysregulation in mouse models of stress and MDD
por: Sharma, Sumeet, et al.
Publicado: (2023)

Gene–Environment Interaction in Major Depression: Focus on Experience-Dependent Biological Systems
por: Lopizzo, Nicola, et al.
Publicado: (2015)

Serum extracellular vesicle microRNA dysregulation and childhood trauma in adolescents with major depressive disorder
por: Ran, Liu-Yi, et al.
Publicado: (2022)

Major depressive disorder (MDD), antidepressants, and uncontrolled hypertension: A report of intraoperative autonomic dysregulation
por: Paraskeva, Anteia, et al.
Publicado: (2022)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
por: Kern, David M., et al.
Publicado: (2023)

Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
por: Magri, Chiara, et al.
Publicado: (2021)

Epigenetic prediction of major depressive disorder
por: Barbu, Miruna C., et al.
Publicado: (2020)

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
por: Schmaal, L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uhe5lmiu1e6lt37m76q3n0uv01